Paper Details 
Original Abstract of the Article :
The anti-seizure effects of progesterone family compounds have long been known. Over the years, however, most studies have focused on progesterone and on its secondary metabolite allopregnanolone (ALLO), with less attention being paid to its primary metabolite 5a-dihydroprogesterone (DHP). Here we r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.seizure.2018.10.012

データ提供:米国国立医学図書館(NLM)

Progesterone and its Metabolites: A Desert Oasis for Seizure Relief

The world of epilepsy research is like a vast desert, with researchers constantly searching for new ways to tame the unpredictable storms of seizures. This review article delves into the intriguing therapeutic potential of progesterone and its neuroactive metabolites - 5a-dihydroprogesterone (DHP) and allopregnanolone (ALLO). They are like hidden oases offering potential relief from the relentless heat of seizures.

Progesterone Family: A Potential Oasis for Seizures

The study found that progesterone and its metabolites, DHP and ALLO, have demonstrated seizure-suppressing effects in various animal models, with the exception of absence seizures. Progesterone and ALLO have also shown promise in clinical trials. The study highlighted the potential benefits of progesterone therapy for women with premenstrual exacerbations of seizures. Additionally, ALLO's C3 methyl analog ganaxolone is currently being explored as a potential anti-seizure drug. While these compounds offer hope, potential drawbacks include their endocrine effects.

Navigating the Desert of Epilepsy Treatment

The study provides valuable insights into the potential benefits of progesterone and its metabolites for seizure control. While further research is needed to fully understand their mechanism of action and mitigate potential side effects, these findings offer hope for developing novel therapies for epilepsy. As researchers, we continue to explore the vast desert of epilepsy, seeking to discover new oases of hope for those affected by this debilitating condition.

Dr.Camel's Conclusion

The study reveals the potential of progesterone and its metabolites in managing seizures. While further research is essential to optimize their use and address potential limitations, this study offers a beacon of hope in the relentless battle against epilepsy. We, as researchers, continue our journey through the desert of medical knowledge, seeking to discover new treatments and improve the lives of those affected by this challenging condition.

Date :
  1. Date Completed 2018-12-17
  2. Date Revised 2018-12-17
Further Info :

Pubmed ID

30391663

DOI: Digital Object Identifier

10.1016/j.seizure.2018.10.012

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.